<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03980704</url>
  </required_header>
  <id_info>
    <org_study_id>Imm1</org_study_id>
    <nct_id>NCT03980704</nct_id>
  </id_info>
  <brief_title>Preoperative High Protein vs Immunodiet in Surgical Cancer Patients</brief_title>
  <acronym>Preop immuno</acronym>
  <official_title>Preoperative Use of the High Protein ONS vs Immunoenhancing ONS in Gastrointestinal Cancer Patients Undergoing Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanley Dudrick's Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanley Dudrick's Memorial Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Immunomodulating nutrition is supposed to reduce the number of complications and the legnth
      of the hospital stay during the postoperative period in patients after major gastrointestinal
      surgery. The aim of the study is to assess the clinical effect of immunomodulating oral
      nutrition in patients undergoing resection for gastrointestinal cancer in the group of
      well-nourished patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Between March 1, 2019, and December 31, 2020, a group of 300 well-nourished patients will be
      enrolled to the study and randomly assigned two one of two groups: A-high protein oral
      supplements (ONS) and B- immunomodulating ONS. The study is designed to test the hypothesis
      that immunonutrition and reduce the incidence of infectious complications after upper
      gastrointestinal surgery; the secondary objective of the study was to evaluate the effect of
      nutritional intervention on overall morbidity and mortality rates, and hospital stay.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2019</start_date>
  <completion_date type="Anticipated">March 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>randomized controlled trial</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Infectious complications</measure>
    <time_frame>6 months</time_frame>
    <description>Number and type of infectious complications</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Surgical complications</measure>
    <time_frame>6 months</time_frame>
    <description>Number and type of surgical complications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay</measure>
    <time_frame>14 days</time_frame>
    <description>Hospital length of stay</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>General Surgery</condition>
  <condition>Cancer of Colon</condition>
  <arm_group>
    <arm_group_label>High Protein</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Provision of 400 ml per day of high protein oral nutritional supplements</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Immuno ONS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Provision of 400 ml per day of immunostimulating oral nutritional supplements</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>IMPACT</intervention_name>
    <description>Administration of oral immunostimulating oral supplement</description>
    <arm_group_label>Immuno ONS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>resource protein</intervention_name>
    <description>Administration of oral high-protein oral supplement</description>
    <arm_group_label>High Protein</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  resectable GI cancer

          -  written consent

        Exclusion Criteria:

          -  inoperable GI cancer

          -  known allergy to the drug
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stanislaw Klek</last_name>
    <role>Study Director</role>
    <affiliation>Stanley Dudrick's Memorial Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stanislaw Klek, PhD</last_name>
    <phone>+48604293566</phone>
    <email>klek@poczta.onet.pl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Eliza Kowalczyk</last_name>
    <phone>+48124446526</phone>
    <email>eliza.kowalczyk@szpitalskawina.pl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Stanley Dudrick's Memorial Hospital</name>
      <address>
        <city>Skawina</city>
        <zip>32-050</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stanislaw Klek, Assoc. Prof.</last_name>
      <phone>+48604293566</phone>
      <email>klek@poczta.onet.pl</email>
    </contact>
    <investigator>
      <last_name>Stanislaw Klek, Assoc. Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>June 5, 2019</study_first_submitted>
  <study_first_submitted_qc>June 7, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 10, 2019</study_first_posted>
  <last_update_submitted>July 5, 2020</last_update_submitted>
  <last_update_submitted_qc>July 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanley Dudrick's Memorial Hospital</investigator_affiliation>
    <investigator_full_name>Stanislaw Klek</investigator_full_name>
    <investigator_title>Head of the Unit</investigator_title>
  </responsible_party>
  <keyword>immunonutrition</keyword>
  <keyword>preoperative nutrition</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colonic Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

